HYPD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.86%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Hyperion DeFi Insider Trading History Chart

Hyperion DeFi Share Price & Price History

^$3.97

▲ +0.36 (9.97%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Hyperion DeFi Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/28/2024	Michael M. Rowe	CEO	Buy	338	$41.60	$14,060.80	1,374
8/26/2024	Michael M. Rowe	CEO	Buy	625	$45.60	$28,500.00	1,036
7/2/2024	Stuart M Grant	Major Shareholder	Buy	18,939	$52.80	$999,979.20	136,426
3/28/2024	Stuart M Grant	Major Shareholder	Buy	1,250	$78.40	$98,000.00	67,883
3/19/2024	Stuart M Grant	Major Shareholder	Buy	625	$98.40	$61,500.00	66,633
3/8/2024	Stuart M Grant	Major Shareholder	Buy	133	$126.40	$16,811.20	66,008
12/4/2023	Michael M. Rowe	CEO	Buy	61	$108.80	$6,636.80	411
9/29/2023	Ellen R Strahlman	Director	Buy	60	$134.40	$8,064.00	938
9/19/2023	Michael M. Rowe	CEO	Buy	17	$132.80	$2,257.60	350
9/15/2023	Michael M. Rowe	CEO	Buy	14	$140.00	$1,960.00	332
8/16/2023	Stuart M Grant	Major Shareholder	Buy	562	$152.80	$85,873.60	65,499
5/31/2023	John P Gandolfo	CFO	Buy	25	$223.20	$5,580.00	100
5/26/2023	Bren Kern	COO	Buy	31	$218.40	$6,770.40	31
5/26/2023	Charles E. Mather, IV	Director	Buy	37	$199.20	$7,370.40	969
5/25/2023	Stuart M Grant	Major Shareholder	Buy	1,103	$212.00	$233,836.00	64,937
5/23/2023	Ellen R Strahlman	Director	Buy	125	$248.00	$31,000.00	663
5/1/2023	Tsontcho Ianchulev	Director	Sell	1,125	$440.00	$495,000.00	4,140
4/27/2023	Tsontcho Ianchulev	Director	Sell	750	$400.00	$300,000.00	5,265
4/14/2023	Tsontcho Ianchulev	Director	Sell	500	$360.00	$180,000.00	6,015
4/11/2023	Tsontcho Ianchulev	Director	Sell	500	$320.00	$160,000.00	6,515
3/31/2023	Tsontcho Ianchulev	Director	Sell	500	$280.00	$140,000.00	7,015

SEC Filings (Institutional Ownership Changes) for Hyperion DeFi (NASDAQ:HYPD)

25.84% of Hyperion DeFi stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Hyperion DeFi Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2025	Lasry Marc	30,618	$34K	0.2%	-98.8%	1.082%
5/12/2025	Virtu Financial LLC	23,065	$25K	0.0%	N/A	0.815%
2/12/2025	Geode Capital Management LLC	577,393	$84K	0.0%	+3.5%	41.539%
11/16/2024	Geode Capital Management LLC	557,994	$0.29M	0.0%	+36.6%	0.871%
11/5/2024	Nations Financial Group Inc. IA ADV	90,900	$47K	0.0%	+78.6%	0.142%
10/23/2024	Financial Management Network Inc.	81,250	$39K	0.0%	N/A	0.151%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	43,784	$26K	0.0%	N/A	0.081%
8/16/2024	SkyView Investment Advisors LLC	146,071	$87K	0.0%	N/A	0.271%
8/15/2024	Armistice Capital LLC	6,060,606	$3.60M	0.0%	N/A	11.250%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	43,784	$26K	0.0%	N/A	0.081%
8/8/2024	Ground Swell Capital LLC	45,258	$27K	0.0%	N/A	0.084%
7/29/2024	Nations Financial Group Inc. IA ADV	50,900	$30K	0.0%	+24.4%	0.094%
5/10/2024	Vanguard Group Inc.	1,790,501	$1.77M	0.0%	+25.2%	3.514%
5/1/2024	BNP Paribas Financial Markets	219,610	$0.22M	0.0%	+1,444.4%	0.431%
4/22/2024	PFG Investments LLC	70,000	$69K	0.0%	N/A	0.148%
3/14/2024	Leo Wealth LLC	16,112	$34K	0.0%	N/A	0.037%
2/13/2024	Armistice Capital LLC	4,378,000	$9.11M	0.1%	+41.8%	9.923%
2/9/2024	Nations Financial Group Inc. IA ADV	40,500	$84K	0.0%	N/A	0.092%
11/15/2023	Armistice Capital LLC	3,087,021	$5.12M	0.1%	N/A	8.079%
10/24/2023	Financial Management Network Inc.	81,250	$0.13M	0.0%	N/A	0.213%
8/10/2023	Meitav Investment House Ltd.	10,350	$1.10M	0.0%	N/A	0.027%
8/4/2023	American International Group Inc.	13,389	$32K	0.0%	N/A	0.035%
8/2/2023	Oak Family Advisors LLC	61,146	$0.15M	0.1%	+36.9%	0.161%
7/24/2023	Meitav Investment House Ltd.	10,350	$1.10M	0.0%	N/A	0.027%
7/18/2023	Denali Advisors LLC	31,500	$75K	0.0%	N/A	0.083%
5/30/2023	BKA Wealth Consulting Inc.	80,000	$0.30M	0.1%	N/A	0.211%
5/2/2023	Leo Brokerage LLC	16,112	$57K	0.0%	N/A	0.042%
5/1/2023	Virtu Financial LLC	20,741	$73K	0.0%	+27.8%	0.055%
4/21/2023	BKA Wealth Consulting Inc.	80,000	$0.30M	0.1%	N/A	0.211%
3/24/2023	Palisade Capital Management LP	315,029	$0.51M	0.0%	N/A	0.872%
2/14/2023	Palisade Capital Management LLC NJ	315,029	$0.51M	0.0%	N/A	0.872%
1/27/2023	Oak Family Advisors LLC	46,073	$75K	0.0%	-22.2%	0.128%
11/4/2022	Vontobel Holding Ltd.	16,840	$33K	0.0%	N/A	0.049%
4/26/2022	AMH Equity Ltd	12,152	$37K	0.0%	-87.8%	0.038%
4/13/2022	Hexagon Capital Partners LLC	10,000	$30K	0.0%	N/A	0.032%
2/9/2022	Saltoro Capital LP	27,773	$0.11M	0.0%	-84.0%	0.098%
1/24/2022	AMH Equity Ltd	100,000	$0.40M	0.6%	N/A	0.352%
11/16/2021	Two Sigma Advisers LP	88,800	$0.44M	0.0%	-52.1%	0.342%
11/16/2021	Two Sigma Investments LP	80,847	$0.40M	0.0%	-63.5%	0.312%
11/12/2021	Renaissance Technologies LLC	197,800	$0.97M	0.0%	+32.6%	0.762%
11/12/2021	Saltoro Capital LP	173,779	$0.85M	0.3%	N/A	0.670%
11/9/2021	BlackRock Inc.	55,836	$0.27M	0.0%	-7.3%	0.215%

Data available starting January 2016

Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.

Today's Range

Now: $3.97

$3.50

$4.09

50 Day Range

MA: $6.70

$3.61

$11.83

52 Week Range

Now: $3.97

$0.85

$17.99

Volume

408,169 shs

Average Volume

328,192 shs

Market Capitalization

$32.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.8

Who are the company insiders with the largest holdings of Hyperion DeFi?: Hyperion DeFi's top insider shareholders include:
Stuart M Grant (Major Shareholder)
Michael M Rowe (CEO)
Learn More about top insider investors at Hyperion DeFi.